References
Heckmann M, Ceballos-Baumann AO, Plewig G (2001) Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 344:488–493
Sloop RR, Cole BA, Escutin RO (1997) Human response to botulinum toxin injection: type B compared with type A. Neurology 49:189–194
Winterholler M, Eisenbarth G, Birklein F (2002) A systematic analysis of dose related local anhidrotic effects of botulinum toxin type B injections as measured by sudometry. Arch Pharmacol 365:S33
Braune C, Erbguth F, Birklein F (2001) Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry. Br J Dermatol 144:111–117
Dressler D, Saberi FA, Benecke R (2002) Botulinum toxin B for the treatment of axillar hyperhidrosis. J Neurol 249:1729–1732
Minor V (1927) Ein Neues Verfahren zu der klinischen Untersuchung der Schweissabsonderung. Z Neurol 101:302–308
Baumann LS (2003) Systemic adverse effects after botulinum toxin type B (Myobloc) injections for the treatment of palmar hyperhidrosis. Arch Dermatol 139:226–227
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hecht, M.J., Birklein, F. & Winterholler, M. Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study. Arch Dermatol Res 295, 318–319 (2004). https://doi.org/10.1007/s00403-003-0440-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-003-0440-5